Experimental Pill Nearly Doubles Survival in Pancreatic Cancer
A late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
Starting your retirement plan at the right age can make all the difference. Explore the benefits of early retirement planning.
26,459 articlesA late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
Tuesday’s session centers on a slate of fresh analyst calls that push CoreWeave, Danaher, HPE, Intuit, Knight-Swift, ...
Sam Valverde says valverde: pulte’s role won’t derail GSE reform as markets digest Bill Pulte's surprise DNI appointm...
President Trump approved a scaled-back AI executive order that relies on a voluntary 30-day review. Investors are wei...
ICLN has surged about 45% year-to-date, signaling a regime shift from subsidy bets to infrastructure demand. A loomin...
A fresh Wall Street call boosts Broadcom stock, signaling a potential historic buy as AI chip demand and a multi-year...
With inflation stubborn and growth resilient, traders are debating whether the Fed will hold rates in June or pivot l...
SanDisk has surged about 500% in 2026 on AI-driven NAND demand. Yet the stock faces a deeply concerning risk: depende...
The U.S. IPO market is rekindling activity in 2026, with more offerings and steadier early trading as investors weigh...
Two AI models weigh in on whether SpaceX’s high-profile IPO will boost or drag Bitcoin in the near term. The verdict ...
Lam Research surged about 21% from its June trough as markets priced in a slower path for rate hikes. This report wei...
The world’s second richest person title is a moving target as stock prices swing. Here's who holds it this week and w...